Electromagnetic Compatibility Requirements

Please find below documentation on the applicable electromagnetic compatibility requirements (EMC) as defined by IEC 60601-1-2 for Niagara devices that appear on the ARTG (Australian Register of Therapeutic Goods) and Medsafe in New Zealand:

The below documents require Adobe Acrobat Reader available here

Electromagnetic Compatability Information for Niagara Devices QD186-2

Clinical studies have shown that with regular use Niagara Cycloid Vibration Therapy products may:

  • Increase local area blood flow.
  • Assist in the reduction of musculoskeletal pain.
  • Increase joint mobilisation.
  • Reduce excess oedema (Swelling) whether the cause is vascular or lymphatic.
  • Assist in the treatment of wounds where an improvement in local circulation is a factor.
  • Assist in the treatment of pressure ulcers where an improvement in local circulation is a factor.
  • Assist in the treatment of cellulitis where an improvement in local circulation is a factor.

Use only as directed and if symptoms persist, please see your doctor, always read and follow the instructions.

Proud Suppliers to

Click each logo to find out more or
Click here to read about how the Australian Institute of Sports (AIS) uses Niagara CVT Devices.

Niagara CVT devices have been used by the Australian Institute of Sports (AIS) since 2006.

Niagara Therapy is a proud supplier to the Fremantle Dockers and Geelong Cats AFL Teams along with the Brisbane BroncosNorth QLD Cowboys and South Sydney Rabbitohs NRL Teams.

These clubs use Niagara CVT devices on players and management throughout their respective seasons and off-seasons.

Niagara is also committed to working with associations and organisations across a variety of health conditions. We are very proud to have become a Commercial Supporter to the Australian Spinal Research Foundation in 2020 and look forward to assisting them in the work they do with Spinal Research.